July 4, 2009
| Bio-IT World > List Rental
List Rental


Postal and Email Subscriber Lists

The Cambridge Healthtech Media Group offers a print publication—Bio-IT World Magazine—and six (6) topic specific eNewsletters focusing on the drug discovery, development, and clinical trials industry. Each medium connects you and your promotional message with tens of thousands of life science professionals who have the authority and resources to recommend or buy your products and services. Cambridge Healthtech Media Group’s subscriber lists help you reach your target audience. All subscribers have given permission to receive mailings and emails about relevant product and information offers. The following subscriber lists are available:

Bio-IT World Magazine

Subscriber Postal List Rentals

  • Base price for postal mailing: $250/M
  • Telemarketing only: $325/M
  • Telemarketing & Postal:  $500/M
    (additional fees apply for selects, etc.)
Subscriber Email List Rentals
  • Base price for emails: $500/M
  • Transmission fee for text: $100/M
  • Transmission fee for HTML: $225/M
    (additional fees apply for selects, etc.)

eNewsletter Email List Rental

Cambridge Healthtech Media Group offers a wide variety of topic specific eNewsletter email subscriber lists. eNewsletter titles are: eCliniqua, Inside IT, Systems Biology, Bio-IT World Weekly Update, PharmaWeek, and Digital Healthcare & Productivity*.

Subscriber Postal List Rentals
  • Base price for email subscriber list: $250/M
  • Transmission fee for text: $100/M
  • Transmission fee for HTML:  $115/M
    (additional fees apply for selects, etc.)
    *Digital Healthcare & Productivity email subscriber list rental: $500/M

Cambridge Healthtech Institute, parent company of Cambridge Healthtech Media Group, offers additional list rental opportunities.

  • CHI's Master File Postal: Database of over 300,000 records. This is derived from conference participants, report buyers, and qualified prospects who are decision makers in pharmaceutical, biotechnology, academic, technology providers, and niche service provider companies.
  • CHI's Master File Email (Products & Service Alert-PSA): This is a scheduled email broadcast from CHI to target segments of CHI's vast internal database of pharmaceutical, biotechnology and life science professionals.

For more details, data selects, and pricing information on subscriber list rentals and CHI's database contacts, please contact Mike Handy.

mhandy@healthtech.com

Bio-IT World is the first publication to focus on the convergence of technology and the life sciences, including the biotechnology, pharmaceutical, biochemical, and healthcare industries.

Bio-IT World provides high-quality, focused information products designed to: advance biotech and pharmaceutical industry business success through effective utilization of bio-IT – including information technology, informatics and data-generating life sciences equipment/tools – through the life sciences R&D value chain.

Bio-IT World subscribers are life science professionals qualified by BPA, a third-party auditing firm, to receive the magazine. With this highly targeted publication, you can connect with more individuals, working on substantial projects, with the authority and resources to recommend or buy your products and services. The Bio-IT World list includes subscribers at the top 100 Biotechnology and Pharmaceutical companies.

Only with the Bio-IT World Subscriber List can you tap into the strongest audience of life science professionals.

Right-click the links below to download list data cards:

Print Subscriber List

E-Mail Subscriber List

Electronic Newsletter E-Mail List

For more information contact:

Mike Handy

mhandy@healthtech.com

tel: 781-972-5492

 

      Click here to login and leave a comment.  

      0 Comments

      Add Comment

      Text Only 2000 character limit

      Page 1 of 1

      White Papers & Special Reports

      thomson reuters image
      Biomarkers: An Indispensible Addition to the Drug Development Toolkit
      Examining the Potential of Biomarkers
      Sponsored by Thomson Reuters

      Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

      Discover the potential of biomarkers to:

      • Improve decision making
      • Accelerate drug development
      • Reduce development costs


      BlueArc_Scientific Data
      Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
      Sponsored by BlueArc

      Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

      • The information technology challenges of gene sequencing
      • “Intelligent” methods for data management and customization
      • System survival tips... Deciding what data to keep or delete
      • New tools to keep scientists ahead of impending data torrents


      SAS Managed image
      Managed Innovation, Assured Compliance
      Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
      Sponsored by SAS
      Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


      Life Science Webcasts & Podcasts

      Presented by Trade Commission of Spain

      Spain Biotech: An Engine for Economic Change 

      TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

      Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

      Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

      Access the podcast 

       



      More Podcasts

      Job Openings

      saic_logo

      MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
      (Bioinformatics Manager)
      SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
      Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

      For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

      (717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.